Cadila Healthcare informs about press release

26 May 2021 Evaluate
Cadila Healthcare has informed that it enclosed a copy of press release dated May 26, 2021 titled ‘Zydus and TLC sign agreement to market Liposomal Amphotericin B, a critical drug to treat Black Fungus or Mucormycosis in India’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

888.20 -2.00 (-0.22%)
30-Jan-2026 11:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1592.00
Dr. Reddys Lab 1222.75
Cipla 1323.50
Zydus Lifesciences 888.20
Lupin 2146.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×